Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy L Weigel

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
The Prostate|March 26, 2004
1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathwayShalini Murthy, Nancy L Weigel
Journal of Andrology|January 10, 2002
Vitamin D and prostate cancerTara C Polek, Nancy L Weigel
The International Journal of Biochemistry & Cell Biology|May 10, 2011
Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminusNicole L Moore, Nancy L Weigel
Experimental Biology and Medicine (Maywood, N.J.)|March 27, 2004
Vitamin D and prostate cancerLaMonica V Stewart, Nancy L Weigel
The Prostate|January 15, 2005
Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cellsLamonica V Stewart, Nancy L Weigel
Endocrinology|February 12, 2010
1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusionMichele N Washington, Nancy L Weigel
Steroids|May 26, 2009
Coactivator selective regulation of androgen receptor activityIrina U Agoulnik, Nancy L Weigel
Journal of Cellular Biochemistry|April 19, 2006
Androgen receptor action in hormone-dependent and recurrent prostate cancerIrina U Agoulnik, Nancy L Weigel
Trends in Endocrinology and Metabolism: TEM|July 11, 2013
Phosphorylation: a fundamental regulator of steroid receptor actionLindsey S Treviño, Nancy L Weigel
Biofactors (Oxford, England)|November 12, 2009
Steroid receptor phosphorylation: Assigning function to site-specific phosphorylationRobert D Ward, Nancy L Weigel
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
The Prostate|March 26, 2004
1alpha,25-dihydroxyvitamin D3 induced growth inhibition of PC-3 prostate cancer cells requires an active transforming growth factor beta signaling pathwayShalini Murthy, Nancy L Weigel
Journal of Andrology|January 10, 2002
Vitamin D and prostate cancerTara C Polek, Nancy L Weigel
The International Journal of Biochemistry & Cell Biology|May 10, 2011
Regulation of progesterone receptor activity by cyclin dependent kinases 1 and 2 occurs in part by phosphorylation of the SRC-1 carboxyl-terminusNicole L Moore, Nancy L Weigel
Experimental Biology and Medicine (Maywood, N.J.)|March 27, 2004
Vitamin D and prostate cancerLaMonica V Stewart, Nancy L Weigel
The Prostate|January 15, 2005
Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cellsLamonica V Stewart, Nancy L Weigel
Endocrinology|February 12, 2010
1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusionMichele N Washington, Nancy L Weigel
Steroids|May 26, 2009
Coactivator selective regulation of androgen receptor activityIrina U Agoulnik, Nancy L Weigel
Journal of Cellular Biochemistry|April 19, 2006
Androgen receptor action in hormone-dependent and recurrent prostate cancerIrina U Agoulnik, Nancy L Weigel
Trends in Endocrinology and Metabolism: TEM|July 11, 2013
Phosphorylation: a fundamental regulator of steroid receptor actionLindsey S Treviño, Nancy L Weigel
Biofactors (Oxford, England)|November 12, 2009
Steroid receptor phosphorylation: Assigning function to site-specific phosphorylationRobert D Ward, Nancy L Weigel
Pageof 8